65.08 Atrial Fibrillation in Patients Undergoing Esophagectomy: Surrogate for Anastomotic Dehiscence? M. thau2, S. Hoffe2, R. Shridhar2, K. Almhanna3, ...
65.08 Atrial Fibrillation in Patients Undergoing Esophagectomy: Surrogate for Anastomotic Dehiscence? M. thau 2, S. Hoffe2, R. Shridhar 2, K. Almhanna 3, A. Salem 1, A. Abbott 3, m. doepker 3, K. Meredith1 1University Of Wisconsin,Surgical Oncology,Madison, WI, USA 2Moffitt Cancer Center And Research Institute,Radiation Oncology,Tampa, FL, USA 3Moffitt Cancer Center And Research Institute,Gastrointestinal Oncology,Tampa, FL, USA Introduction: Neoadjuvant chemoradiation (NT) has become the standard for patients with locally advanced esophageal cancer. Thirty percent of patients who undergo esophagectomy will develop atrial fibrillation (AF). NT may contribute to patients developing AF and this may be a surrogate for anastomotic dehiscence (AD). Methods: We queried a prospective esophageal database to identify patients who underwent esophagectomy with or without NT. Demographics and post-operative complications were all compared with fisher exact test and considered significant at p
